Emerging Therapies for the Myelodysplastic Syndromes
Despite considerable advances in our understanding of the molecular and epigenetic underpinnings of the myelodysplastic syndromes (MDS), this diverse group of myeloid neoplasms remains a significant clinical challenge. Considerable barriers to timely development of effective therapy include the dive...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Atlantis Press
2019-12-01
|
| Series: | Clinical Hematology International |
| Subjects: | |
| Online Access: | https://www.atlantis-press.com/article/125925038/view |